The ever-increasing demand for protein rich meat & dairy products & rising focus on animal health & safety has propelled the animal vaccines market growth in recent years. Vaccination has long been an effective way to reduce the risk of diseases in farm animals and domestic pets, and is a key tool in maintaining animal health and welfare. It continues to play a key role in preventative health and disease control programs to avoid epidemics like bird flu and is constantly undergoing clinical research for the development of safe, effective and quality vaccines for pets and farm animals that prevent or lessen clinical signs of such diseases.
For example, on March 18th, 2019, Merck Animal Health launched its new poultry vaccine Innovax ND-ILT that offers a single injection protection against Newcastle disease, ILT and Marek’s disease. This is an apt instance enumerating the robust expansion of the global animal vaccines industry.
Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/3117
The global cattle-based animal vaccines market is anticipated to witness commendable growth in the years to come, owing to the rising cases of infectious outbreaks and growing consumption of meat & dairy products. According to the U.S. Department of Agriculture (USDA) reports, the total red meat and poultry production increased by 2% in 2019, to reach a new record of 104.7 billion pounds. To meet such increasing demands, cattle producers are found to periodically torture cattle with advanced vaccines to prevent infectious diseases that could cause reduced production, fertility or even death in animals.
Outbreaks of certain highly-infectious diseases also lead to programs pertaining to mass slaughter and corpse disposal of infected animals to prevent further spread of disease, which eventually leads to massive economic loss for cattle producers as well as the meat export industry. Reportedly, in October 2017, about 4000 cattle worth over $8 million were slaughtered in New Zealand to halt the spread of the cattle disease Mycoplasma bovis.
Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/3117
In developed countries like the UK, almost half of the meat consumed is from poultry, while over 12 billion eggs are consumed annually in the region. The poultry sector plays a major role in providing with safe and affordable food, and to meet growing demands, these animals are constantly subjected to strict biosecurity and management systems to prevent illness and outbreaks of disease to benefit both poultry and consumer health. Recently, the Advisory Committee on Microbiological Safety of Food (ACMSF) recognized that major reductions in the risk from Salmonella in eggs aptly highlight the key role of vaccination on farms, protecting consumer health, further stimulating the growth of animal vaccines industry.
Parasitic diseases are a global phenomenon and are considered to be a major cause toward deteriorating animal health and reduced productivity. Parasites that affect animal body, such as mites, fleas, ticks, lice and flies are responsible for zoonoses, organ condemnation and subject huge economic losses in animal production. According to the U.S. National Center for Biotechnology Information 2015 reports, cases of gastrointestinal (GI) parasitic infections caused economic losses of around Rs. 97.37 crores in adult cattle and Rs. 21.79 crores in yearling sheep in Rajasthan, India.
A reliable study however, also showed that 4% to 18% of increase in milk production in UP, was achieved following an anthelmintic treatment, thus validating that with various technological advances, the parasitic vaccines market will witness tremendous growth in the coming years. As a matter of fact, parasitic vaccines market will register revenues worth around $815.4 million by 2025.
Speaking on the regional hierarchy, the U.S. animal vaccines market is anticipated to witness commendable growth by 2025. Being one of the largest meat producers in the world, the country is increasingly focusing on vaccine-related programs to avoid disease outbreaks for protecting both consumer health as well as to avoid major economic loss from the domestic meat production & export industry.
For instance, in 2018, beef exports in the U.S. increased by 10.3%, pork by 4.2%, and broiler exports by 4.1%, than that recorded in 2017. Increasing customer spending on pet healthcare enabled by surplus disposable incomes, inventions in customized veterinary medicine are also some factors that have been responsible for the expansion of the U.S. animal vaccines industry.
Animal vaccines play a significant role in animal as well as human health protection as they reduce the need for antibiotics to treat companion and farm animals. The rapid adoption of advanced clinical technologies and the need to confront emerging infectious diseases will help augment animal vaccines market size, slated to cross $9 billion by 2025.